Loading...
Please wait, while we are loading the content...
Similar Documents
Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
| Content Provider | Scilit |
|---|---|
| Author | Deng, Xia Zhao, Li Guo, Chang Yang, Ling Wang, Dong Li, Yanyan Xia, Hong Wang, Chenxi Cai, Zhensheng Li, Lian Zhao, Zhicong Yuan, Guoyue |
| Copyright Year | 2020 |
| Description | Aim: We detected whether serum asprosin levels play a role in the occurrence and development of albuminuria in patients with type 2 diabetes mellitus (T2DM), which has not been previously discussed. Methods: Based on urinary albumin/creatinine ratio (UACR), 207 T2DM patients were divided into T2DM patients with normoalbuminuria (UACR< 30 mg/g), microalbuminuria (30≤UACR< 300 mg/g), and macroalbuminuria (UACR≥ 300 mg/g). Serum asprosin levels were determined by enzyme-linked immunosorbent assay. Results: Comparatively, the serum asprosin levels in T2DM patient groups with macroalbuminuria [2.37 (1.63– 3.57)] and microalbuminuria [2.10 (1.60– 2.90)] were significantly increased than the normoalbuminuria group [1.59 (1.18– 2.09)] (P< 0.001). Importantly, the serum level of asprosin was positively correlated with UACR (r=0.304, P< 0.001), creatinine (r=0.157, P=0.024), blood urea nitrogen (BUN) (r=0.244, P< 0.001), and negatively with glomerular filtration rate (eGFR) (r=− 0.159, P=0.022). Furthermore, multiple stepwise regression analyses showed that asprosin was significantly and independently related to UACR, BUN, DBP, and LDL-C (P< 0.05). Besides, after adjustment for the confounders, the serum asprosin level was constantly and independently associated with the development of albuminuria in T2DM patients [OR (95% CI): 2.003 (1.37∼ 2.928), P < 0.001]. Conclusion: Obviously, the serum asprosin level was independently correlated with UACR in T2DM patients, which implies circulating asprosin may play an essential role in the pathogenesis of diabetic nephropathy. |
| Related Links | https://www.dovepress.com/getfile.php?fileID=63733 |
| Ending Page | 4351 |
| Page Count | 11 |
| Starting Page | 4341 |
| ISSN | 11787007 |
| DOI | 10.2147/dmso.s283413 |
| Journal | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy |
| Volume Number | 13 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2020-11-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Endocrinology and Metabolism Peripheral Vascular Disease Asprosin Type 2 Diabetes Mellitus Diabetic Nephropathy |
| Content Type | Text |
| Resource Type | Article |
| Subject | Internal Medicine Pharmacology |
